IL106622A - Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL106622A
IL106622A IL10662293A IL10662293A IL106622A IL 106622 A IL106622 A IL 106622A IL 10662293 A IL10662293 A IL 10662293A IL 10662293 A IL10662293 A IL 10662293A IL 106622 A IL106622 A IL 106622A
Authority
IL
Israel
Prior art keywords
carbon atoms
chain
straight
hydroxyl
phenyl
Prior art date
Application number
IL10662293A
Other languages
English (en)
Other versions
IL106622A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL106622A0 publication Critical patent/IL106622A0/xx
Publication of IL106622A publication Critical patent/IL106622A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10662293A 1992-08-11 1993-08-09 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives their preparation and pharmaceutical compositions containing them IL106622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226519A DE4226519A1 (de) 1992-08-11 1992-08-11 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate

Publications (2)

Publication Number Publication Date
IL106622A0 IL106622A0 (en) 1993-12-08
IL106622A true IL106622A (en) 1997-02-18

Family

ID=6465285

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10662293A IL106622A (en) 1992-08-11 1993-08-09 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US5597833A (xx)
EP (1) EP0582908B1 (xx)
JP (1) JPH06157463A (xx)
KR (1) KR940003936A (xx)
CN (1) CN1087337A (xx)
AT (1) ATE166645T1 (xx)
AU (1) AU668574B2 (xx)
CA (1) CA2103521A1 (xx)
CZ (1) CZ151193A3 (xx)
DE (2) DE4226519A1 (xx)
DK (1) DK0582908T3 (xx)
ES (1) ES2117070T3 (xx)
FI (1) FI933512A (xx)
HU (1) HUT70041A (xx)
IL (1) IL106622A (xx)
MX (1) MX9304582A (xx)
MY (1) MY108877A (xx)
NO (1) NO179513C (xx)
NZ (1) NZ248343A (xx)
PL (1) PL300026A1 (xx)
SK (1) SK86593A3 (xx)
ZA (1) ZA935795B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
PA8619901A1 (es) 2003-12-12 2005-11-25 Wyeth Corp Quinolinas utiles en el tratamiento de enfermedades cardiovasculares
MX2008001386A (es) * 2005-08-10 2008-04-07 Takeda Pharmaceutical Agente terapeutico para diabetes.
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
EP3102209B1 (en) 2014-02-04 2021-04-07 Bioscience Pharma Partners, LLC Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
JPH0742488Y2 (ja) * 1989-05-23 1995-10-04 川崎重工業株式会社 移動床型脱じん・反応装置
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
NO932709L (no) 1994-02-14
SK86593A3 (en) 1994-06-08
FI933512A (fi) 1994-02-12
IL106622A0 (en) 1993-12-08
JPH06157463A (ja) 1994-06-03
DE4226519A1 (de) 1994-02-17
EP0582908A1 (de) 1994-02-16
DK0582908T3 (da) 1999-01-18
CZ151193A3 (en) 1994-03-16
MX9304582A (es) 1994-02-28
HUT70041A (en) 1995-09-28
NO932709D0 (no) 1993-07-27
CN1087337A (zh) 1994-06-01
HU9302313D0 (en) 1993-10-28
NO179513B (no) 1996-07-15
ZA935795B (en) 1994-03-07
FI933512A0 (fi) 1993-08-09
NZ248343A (en) 1995-03-28
ES2117070T3 (es) 1998-08-01
AU668574B2 (en) 1996-05-09
MY108877A (en) 1996-11-30
DE59308603D1 (de) 1998-07-02
CA2103521A1 (en) 1994-02-12
ATE166645T1 (de) 1998-06-15
EP0582908B1 (de) 1998-05-27
NO179513C (no) 1996-10-23
US5597833A (en) 1997-01-28
PL300026A1 (en) 1994-03-21
KR940003936A (ko) 1994-03-14
AU4425393A (en) 1994-02-17

Similar Documents

Publication Publication Date Title
MX9203744A (es) Analogos de camptotecina solubles en agua utiles para inhibir el crecimiento de celulas de tumor de animal.
GB9828511D0 (en) Chemical compounds
IE890500L (en) 3-alkenyl-1-azabicyclo£3.2.0|hept-2-ene-2-carboxylic acid compounds
IL106622A (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives their preparation and pharmaceutical compositions containing them
ES2158876T3 (es) Derivado de galantamina, un procedimiento para su preparacion y su utilizacion como medicamento.
HU904956D0 (en) Process for producing benzopyrane derivatives and pharmaceutical preparatives containing such active agents
AU581324B2 (en) Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
ES8305718A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
WO2005081972A2 (en) Maleiimide anti-tumor phosphatase inhibitors
AU2290683A (en) Phenoxymethyl pyridine derivatives
MA27260A1 (fr) Nouveaux dérivés de 3-(4-oxo-4H-chromén-2-yl)-(1H)-quinoléine-4-ones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
ES8800156A1 (es) Procedimiento para preparar nuevos derivados 3-piridilmetilnaftilicos
DE69409734D1 (de) Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
JPS5470830A (en) Color photographic material
AU7998087A (en) 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them
FR2450106A1 (fr) Compositions pharmaceutiques ou veterinaires renfermant une quantite physiologiquement active d'une phenylethylamine, a activite de stimulation sexuelle

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void